Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies

References

• Rabin RA, George TP. A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use. Am J Addict. 2015;24:105–16. doi:10.1111/ajad.12186.
   PubMed Web of Science ®Google Scholar
• Schauer GL, Berg CJ, Kegler MC, Donovan DM, Windle M. Assessing the overlap between tobacco and marijuana: trends in patterns of co-use of tobacco and marijuana in adults from 2003–2012. Addict Behav. 2015;49:26–32. doi:10.1016/j.addbeh.2015.05.012.
   PubMed Web of Science ®Google Scholar
• Meier E, Hatsukami DK. A review of the additive health risk of cannabis and tobacco co-use. Drug Alcohol Depen. 2016;166:6–12. doi:10.1016/j.drugalcdep.2016.07.013.
   PubMed Web of Science ®Google Scholar
• Fitzke RE, Davis JP, Pedersen ER. Co-use of tobacco products and cannabis among veterans: a preliminary investigation of prevalence and associations with mental health outcomes. J Psychoactive Drugs. 2022;54:250–57. doi:10.1080/02791072.2021.1956026.
   PubMed Web of Science ®Google Scholar
• Hunt GE, Large MM, Cleary M, Lai HMX, Saunders JB. Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: systematic review and meta-analysis. Drug Alcohol Depen. 2018;191:234–58. doi:10.1016/j.drugalcdep.2018.07.011.
   PubMed Web of Science ®Google Scholar
• Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness a population-based prevalence study. JAMA. 2000;284:2606–10. doi:10.1001/jama.284.20.2606.
   PubMed Web of Science ®Google Scholar
• Kozak K, Barr MS, George TP. Traits and biomarkers for addiction risk in schizophrenia. Curr Addict Rep. 2017;4:14–24. doi:10.1007/s40429-017-0130-6.
   Google Scholar
• Rabin RA, George TP. Understanding the link between cannabinoids and psychosis. Clin Pharmacol Ther. 2017;101:197–99. doi:10.1002/cpt.421.
   PubMed Web of Science ®Google Scholar
• Kim HS, Hodgins DC, Garcia X, Ritchie EV, Musani I, McGrath DS, von Ranson KM. A systematic review of addiction substitution in recovery: clinical lore or empirically-based? Clin Psychol Rev. 2021;89:102083. doi:10.1016/j.cpr.2021.102083.
   PubMed Web of Science ®Google Scholar
• Koola MM, Boggs DL, Kelly DL, Liu F, Linthicum JA, Turner HE, McMahon RP, Gorelick DA. Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. Psychiatry Res. 2013;209:273–8. doi:10.1016/j.psychres.2013.07.044.
   PubMed Web of Science ®Google Scholar
• Levin KH, Copersino ML, Heishman SJ, Liu F, Kelly DL, Boggs DL, Gorelick DA. Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend. 2010;111:120–7. doi:10.1016/j.drugalcdep.2010.04.010.
   PubMed Web of Science ®Google Scholar
• Allsop DJ, Dunlop AJ, Sadler C, Rivas GR, McGregor IS, Copeland J. Changes in cigarette and alcohol use during cannabis abstinence. Drug Alcohol Depen. 2014;138:54–60. doi:10.1016/j.drugalcdep.2014.01.022.
   PubMed Web of Science ®Google Scholar
• Shelef K, Diamond GS, Diamond GM, Myers MG. Changes in tobacco use among adolescent smokers in substance abuse treatment. Psychol Addict Behav. 2009;23:355. doi:10.1037/a0014517.
   PubMed Web of Science ®Google Scholar
• Kouri EM, Pope HG Jr. Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol. 2000;8:483–92. doi:10.1037/1064-1297.8.4.483.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112:393. doi:10.1037/0021-843X.112.3.393.
   PubMed Web of Science ®Google Scholar
• Schaub M, Gmel G, Annaheim B, Mueller MAX, Schwappach D. Leisure time activities that predict initiation, progression and reduction of cannabis use: a prospective, population-based panel survey. Drug Alcohol Rev. 2010;29:378–84. doi:10.1111/j.1465-3362.2009.00156.x.
   PubMed Web of Science ®Google Scholar
• McClure EA, Baker NL, Gray KM. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents. Am J Drug Alcohol Abuse. 2014;40:285–91. doi:10.3109/00952990.2013.878718.
   PubMed Web of Science ®Google Scholar
• Hughes JR, Naud S, Budney AJ, Fingar JR, Callas PW. Attempts to stop or reduce daily cannabis use: an intensive natural history study. Psychol Addict Behav. 2016;30:389–97. doi:10.1037/adb0000155.
   PubMed Web of Science ®Google Scholar
• Rabin RA, Dermody SS, George TP. Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. Drug Alcohol Depen. 2018;185:181–88. doi:10.1016/j.drugalcdep.2017.12.017.
   PubMed Web of Science ®Google Scholar
• Morisano D, Bacher I, Audrain-McGovern J, George TP. Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Can J Psychiatry. 2009;54:356–67. doi:10.1177/070674370905400603.
   PubMed Web of Science ®Google Scholar
• Schnell T, Becker T, Thiel MC, Gouzoulis-Mayfrank E. Craving in patients with schizophrenia and cannabis use disorders. Can J Psychiatry. 2013;58:646–9. doi:10.1177/070674371305801111.
   PubMed Web of Science ®Google Scholar
• Lo S, Heishman SJ, Raley H, Wright K, Wehring HJ, Moolchan ET, Feldman S, Liu F, McMahon RP, Richardson CM, et al. Tobacco craving in smokers with and without schizophrenia. Schizophr Res. 2011;127:241–45.
   PubMed Web of Science ®Google Scholar
• Weinberger AH, Reutenauer EL, Allen TM, Termine A, Vessicchio JC, Sacco KA, Easton CJ, McKee SA, George TP. Reliability of the fagerström test for nicotine dependence, minnesota nicotine withdrawal scale, and tiffany questionnaire for smoking urges in smokers with and without schizophrenia. Drug Alcohol Depen. 2007;86:278–82. doi:10.1016/j.drugalcdep.2006.06.005.
   PubMed Web of Science ®Google Scholar
• Yeap ZJS, Marsault J, George TP, Mizrahi R, Rabin RA. Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders? Am J Addict. 2023;32:367–375. doi:10.1111/ajad.13394.
   PubMed Web of Science ®Google Scholar
• Romero-Sanchiz P, Mahu IT, Barrett SP, Salmon JP, Al-Hamdani M, Swansburg JE, Stewart SH. Craving and emotional responses to trauma and cannabis cues in trauma-exposed cannabis users: influence of PTSD symptom severity. Addict Behav. 2022;125:107126. doi:10.1016/j.addbeh.2021.107126.
   PubMed Web of Science ®Google Scholar
• Heishman SJ, Evans RJ, Singleton EG, Levin KH, Copersino ML, Gorelick DA. Reliability and validity of a short form of the Marijuana Craving Questionnaire. Drug Alcohol Depend. 2009;102:35–40. doi:10.1016/j.drugalcdep.2008.12.010.
   PubMed Web of Science ®Google Scholar
• Witkiewitz K, Stein ER, Votaw VR, Hallgren KA, Gibson BC, Boness CL, Pearson MR, Maisto SA. Constructs derived from the addiction cycle predict alcohol use disorder treatment outcomes and recovery 3 years following treatment. Psychol Addict Behav. 2023;37:376. doi:10.1037/adb0000871.
   PubMed Web of Science ®Google Scholar
• Dondé C, Achim AM, Brunelin J, Poulet E, Mondino M, Haesebaert F. A meta-analysis of craving studies in schizophrenia spectrum disorders. Schizophr Res. 2020;222:49–57. doi:10.1016/j.schres.2020.05.046.
   PubMed Web of Science ®Google Scholar
• Salazar E, Ren C, Rostron BL, Solomon G. Modeling mortality risk effects of cigarettes and smokeless tobacco: results from the national health interview survey linked mortality file data. BMC Public Health. 2021;21:1773. doi:10.1186/s12889-021-11801-w.
   PubMed Web of Science ®Google Scholar
• Kozak-Bidzinski K, Lowe DJE, Sanches M, Sorkhou M, Boileau I, Kiang M, Blumberger DM, Remington G, Ma C, Castle DJ, et al. Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophrenia. Schizophrenia (Heidelb). 2022;8:2. doi:10.1038/s41537-022-00210-6.
   PubMedGoogle Scholar
• Rabin RA, Barr MS, Goodman MS, Herman Y, Zakzanis KK, Kish SJ, Kiang M, Remington G, George TP. Effects of extended cannabis abstinence on cognitive outcomes in cannabis dependent patients with schizophrenia vs non-psychiatric controls. Neuropsychopharmacology. 2017;42:2259–71. doi:10.1038/npp.2017.85.
   PubMed Web of Science ®Google Scholar
• Wechsler D. Wechsler test of adult reading: WTAR. San Antonio, TX: The Psychological Corporation; 2001.
   Google Scholar
• Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1986;13:261–76. doi:10.1093/schbul/13.2.261.
   Web of Science ®Google Scholar
• Sobell LC, Sobell MB, Leo GI, Cancilla A. Reliability of a timeline method: assessing normal drinkers’ reports of recent drinking and a comparative evaluation across several populations. Br J Addict. 1988;83:393–402. doi:10.1111/j.1360-0443.1988.tb00485.x.
   PubMedGoogle Scholar
• Budney AJ, Novy PL, Hughes JR. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 1999;94:1311–22. doi:10.1046/j.1360-0443.1999.94913114.x.
   PubMed Web of Science ®Google Scholar
• Rabin RA, Kozak K, Zakzanis KK, Remington G, Stefan C, Budney AJ, George TP. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. Schizophr Res. 2018;194:47–54. doi:10.1016/j.schres.2017.05.006.
   PubMed Web of Science ®Google Scholar
• Dekker N, Koeter M, Van Den Brink W. Craving for cannabis in patients with psychotic disorder, their non-affected siblings and healthy controls: psychometric analysis of the obsessive compulsive drug use scale. Int J Methods Psychiatr Res. 2012;21:286–300. doi:10.1002/mpr.1362.
   PubMed Web of Science ®Google Scholar
• Guillot CR, Blumenthal H, Zvolensky MJ, Schmidt NB. Anxiety sensitivity components in relation to alcohol and cannabis use, motives, and problems in treatment-seeking cigarette smokers. Addict Behav. 2018;82:166–73. doi:10.1016/j.addbeh.2018.03.008.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Budney AJ, Lynskey MT. The co-occurring use and misuse of cannabis and tobacco: a review. Addiction. 2012;107:1221–33. doi:10.1111/j.1360-0443.2012.03837.x.
   PubMed Web of Science ®Google Scholar
• Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction. 2008;103:1678–86. doi:10.1111/j.1360-0443.2008.02292.x.
   PubMed Web of Science ®Google Scholar
• Gamaleddin I, Wertheim C, Zhu AZX, Coen KM, Vemuri K, Makryannis A, Goldberg SR, Le Foll B. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking. Addict Biol. 2012;17:47–61. doi:10.1111/j.1369-1600.2011.00314.x.
   PubMed Web of Science ®Google Scholar
• Navarrete F, Rodríguez-Arias M, Martín-García E, Navarro D, García-Gutiérrez MS, Aguilar MA, Aracil-Fernández A, Berbel P, Miñarro J, Maldonado R, et al. Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine. Neuropsychopharmacology. 2013;38:2515–24. doi:10.1038/npp.2013.157.
   PubMed Web of Science ®Google Scholar
• Moss TG, Sacco KA, Allen TM, Weinberger AH, Vessicchio JC, George TP. Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug Alcohol Depen. 2009;104:94–99. doi:10.1016/j.drugalcdep.2009.04.005.
   PubMed Web of Science ®Google Scholar
• Orellana G, Slachevsky A. Executive functioning in schizophrenia. Front Psychiatry. 2013;4:35. doi:10.3389/fpsyt.2013.00035.
   PubMedGoogle Scholar
• Fishbein DH, Hyde C, Eldreth D, Paschall MJ, Hubal R, Das A, Tarter R, Ialongo N, Hubbard S, Yung B, et al. Neurocognitive skills moderate urban male adolescents’ responses to preventive intervention materials. Drug Alcohol Depend. 2006;82:47–60. doi:10.1016/j.drugalcdep.2005.08.008.
   PubMed Web of Science ®Google Scholar
• Haney M, Bedi G, Cooper ZD, Glass A, Vosburg SK, Comer SD, Foltin RW. Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status. Biol Psychiatry. 2013;73:242–8. doi:10.1016/j.biopsych.2012.07.028.
   PubMed Web of Science ®Google Scholar
• Rabin RA, Giddens JL, George TP. Relationship between tobacco and cannabis use status in outpatients with schizophrenia. Am J Addict. 2014;23:170–5. doi:10.1111/j.1521-0391.2013.12084.x.
   PubMed Web of Science ®Google Scholar
• Huang W, Fang S, Zhang J, Baoping X. Effect of repetitive transcranial magnetic stimulation on cigarette smoking in patients with schizophrenia. Shanghai Jingshen Yixue. 2016;28:309–17.
   Google Scholar
• Prikryl R, Ustohal L, Kucerova HP, Kasparek T, Jarkovsky J, Hublova V, Vrzalova M, Ceskova E. Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2014;49:30–5. doi:10.1016/j.pnpbp.2013.10.019.
   PubMed Web of Science ®Google Scholar
• Přikryl R, Hana PK, Kašpárek T, Vrzalová M, Češková E, Sochorová A. The effect of repetitive transcranial magnetic stimulation on nicotinism in schizophrenia: an open study. Czech Slovak Psychiatry. 2013;109:5.
   Google Scholar
• Wing VC, Bacher I, Wu BS, Daskalakis ZJ, George TP. High frequency repetitive transcranial magnetic stimulation reduces tobacco craving in schizophrenia. Schizophr Res. 2012;139:264–66. doi:10.1016/j.schres.2012.03.006.
   PubMed Web of Science ®Google Scholar
• Lefaucheur J-P, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125:2150–206. doi:10.1016/j.clinph.2014.05.021.
   PubMed Web of Science ®Google Scholar
• Moretti J, Poh EZ, Rodger J. rTMS-Induced changes in glutamatergic and dopaminergic systems: relevance to cocaine and methamphetamine use disorders. Front Neurosci. 2020;14:137. doi:10.3389/fnins.2020.00137.
   PubMed Web of Science ®Google Scholar
• Cooper ZD, Craft RM. Sex-dependent effects of cannabis and cannabinoids: a translational perspective. Neuropsychopharmacology. 2018;43:34–51. doi:10.1038/npp.2017.140.
   PubMed Web of Science ®Google Scholar
• Smith PH, Bessette AJ, Weinberger AH, Sheffer CE, McKee SA. Sex/Gender differences in smoking cessation: a review. Prev Med. 2016;92:135–40. doi:10.1016/j.ypmed.2016.07.013.
   PubMed Web of Science ®Google Scholar